Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group-Reference-Cited by-同舟云学术

Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

Published:1999-01 Issue:1-2 Volume:35 Page:91-98
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Fleming Donald R.¹²,Wolf Steven N.³²,Fay Joseph W.⁴²,Brown Randy A.⁵²,Lynch Joseph P.⁶²,Bolwell Brian J.⁷²,Stevens Don A.¹²,Goodman Stacy A.³²,Greer John P.³²,Stein Richard S.³²,Pineiro Luis A.⁴²,Collins Robert H.⁴²,Goldsmith Linda Jane¹²,Herzig Geoffrey P.⁵²,Herzig Roger H.¹²

Affiliation:

1. University of Louisville, School of Medicine, James Graham Brown Cancer Center, Division of Hematology/Oncology, 529 South Jackson Street, Room 230, Louisville, KY, 40202

2. Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

3. Vanderbrlt Universrty Medical Center, Bone Marrow Transplantation Program 808 Oxford House, Vanderbilr University, Nashville, TN, 37232

4. Baylor University Medical Center, Charles A. Sammons Cancer Center, Blood and Marrow Transplantation Services, 3535 Worth Street, Dallas, TX, 75246

5. Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, 660 South Euclid, Box 8007, Saint Louis, MO, 63110

6. West Virginia University Medical Center, Mary Babb Randolph Cancer Center, Bone Marrow Transplanration Program, Section of Hematology/Oncology, I Medical Center Drive, Morgantown, WV, 26506

7. Cleveland Clinic Foundrrtion, 9500 Euclid Avenue, Cleveland, OH, 44106, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428199909145708

Reference38 articles.

1. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.

2. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

3. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

4. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors;Pharmaceutical Research;2020-07

2. Hepatotoxicity and Hepatic Dysfunction;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018

3. Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE;Turkish Journal of Hematology;2016-08-15

4. Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2013-08

5. Hepatotoxicity and Hepatic Dysfunction;The MASCC Textbook of Cancer Supportive Care and Survivorship;2010